Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – PRNewswire
/PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI)…
SILVER SPRING, Md., April 9, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
“Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with…
-
Business15 hours agoIAG shares are racing higher today. Here’s why
-
Noosa News13 hours agoProp Allan Alaalatoa returns to the Wallabies line-up for Rugby Championship game against Argentina
-
General17 hours agoQueensland government dumps Forest Wind project
-
Noosa News17 hours agoLifeFlight airlifts man after boat runs aground